Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Online business Stages for Little Retailers
- 1st human missions to Mars should hunt for signs of life, report says
- The most effective method to Promoter for Cutthroat Medical attendant Compensations in Your Medical services Office
- Easter Island quarry reveals how Polynesians made enigmatic stone statues
- 10 Hints and Deceives to Expand Cell Phone Information Use: Capitalize on Your Information
- Bomb blast in packed Nigerian mosque kills five
- Ariana Grande to host 'Saturday Night Live' Christmas show with Cher as musical guest, returning after nearly 40 years
